Shagun Singh

Stock Analyst at RBC Capital

(0)
# 3384
Out of 5,240 analysts
192
Total ratings
41.94%
Success rate
0.72%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
Stryker
Reiterates: Outperform
425 425
362.71 17.17% 18 Jan 7, 2025
Outset Medical
Reiterates: Sector Perform
3 3
0.81 270.37% 9 Jan 7, 2025
Edwards Lifesciences
Maintains: Outperform
80 85
71.02 19.68% 18 Dec 5, 2024
Nevro
Reiterates: Sector Perform
7 7
3.67 90.74% 9 Nov 12, 2024
Globus Medical
Maintains: Outperform
80 92
88.01 4.53% 5 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
260 260
169.94 53% 3 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
120 125
104.65 19.45% 12 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
275 245
178.99 36.88% 19 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
120 115
79.23 45.15% 4 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
95 98
95.55 2.56% 13 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
525 555
538.11 3.14% 12 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
178 181
144.67 25.11% 15 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
98 105
85.13 23.34% 18 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 11
7.67 43.42% 5 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
205 222
253.66 -12.48% 10 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 130
113.03 15.01% 10 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
65
35.79 81.61% 1 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Sector Perform
71 71
n/a n/a 5 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
58
n/a n/a 5 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
24
n/a n/a 1 Apr 8, 2021